Back to mobile site

More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+700.0% Growth)
- Ratings (7.0 Score)

Upcoming Events

- Earnings (11/3/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 96.06 -2.6 (2.64%)
Prev. Close $98.66  
Open$98.81 
52 Wk High$ 
52 Wk Low$ 
Day High$99.25 
Day Low$95.71 
P/E N/A  
EPS$ 
Volume1,195,347 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, AZN, MRK (more...)

Sep 18, 2026 04:42 PM Form 4 BioNTech SE For: Sep 17 Filed by: Sahin Ugur
Sep 18, 2026 04:10 PM Form 6-K BioNTech SE For: Sep 18
Sep 16, 2026 04:46 PM Form 4 BioNTech SE For: Sep 15 Filed by: Sahin Ugur
Sep 16, 2026 08:40 AM UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates
Sep 16, 2026 04:57 AM BioNTech (BNTX) PT Raised to $140 at Berenberg
Sep 15, 2026 09:00 AM A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
Sep 14, 2026 04:51 PM Form 4 BioNTech SE For: Sep 11 Filed by: Sahin Ugur
Sep 14, 2026 08:29 AM Form 6-K BioNTech SE For: Sep 14
Sep 14, 2026 04:27 AM BioNTech drug shows doubled survival in lung cancer trial
Sep 14, 2026 04:00 AM BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patie
View All Articles

Entities mentioned with bntx

View All Entities